Monash BDI secures $16m in NHMRC Ideas Grant Scheme

Monash Biomedicine Discovery Institute (BDI) researchers have been awarded more than $16 million across 16 projects in the highly competitive NHMRC Ideas Grant Scheme for innovative research projects.

The National Health and Medical Research Council (NHMRC) Ideas Grants support innovative and creative research, researchers at all career stages, and any area of health and medical research from discovery to implementation.

Awards to BDI researchers reflect the scope of research capability at the BDI, everything from understanding embryo development, to the role of stress in obesity, to how to control antibiotic resistant pathogens, to using the immune system to tackle cancer, and much more.

Congratulations to all who were supported in this 2020 Ideas Grant round. It was an incredibly competitive year and commiserations go to all those who missed out.

We acknowledge the hard work of the NHMRC in managing the peer review process under extremely trying circumstances.

Federal Health Minister, The Honourable Greg Hunt MP, today announced $260 million of funding in this scheme.

Congratulations to all of our researchers who have secured funding in this scheme.

  • Dr Thierry Jarde: Characterising the function of niche-derived Neuregulin 1 in colorectal cancer.

Researchers from the Faculty of Medicine, Nursing and Health Sciences were awarded in excess of $40 million across 43 projects in the NHMRC Ideas Grant Scheme. Read about the other funded projects across the Faculty here.

Read about successful recipients across Monash University here and read the full list of national recipients on the NHMRC site.

About the Monash Biomedicine Discovery Institute at Monash University

Committed to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.